Related Experiment Video
Updated: May 22, 2026

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
PSMA7 inhibits the tumorigenicity of A549 human lung adenocarcinoma cells
Jia-Yu Tan1, Xiang Huang, Ya-Ling Luo
1Intensive Care Unit, Bo'ai Hospital Affiliated with Southern Medical University, Zhongshan 528403, China.
Abstract:
The gene for proteasome subunit alpha type-7 (PSMA7) is located in chromosomal 20q13.33, a region frequently amplified in tumor. In this study, we employed A549 human lung adenocarcinoma cells and showed that PSMA7 inhibits the proliferation, tumorigenicity and invasion of A549 cells in vitro. Moreover, both gain and loss of function studies demonstrated that PSMA7 modulates the tumorigenicity of A549 cells in a xenograft nude mice model. In conclusion, these results identify inhibitory effects associated with PSMA7 that affect the tumorigenicity of A549 cells, suggesting PSMA7 as a potential tumor biomarker.
Insights
Proteasome subunit alpha type-7 (PSMA7) inhibits lung adenocarcinoma cell proliferation and invasion. This suggests PSMA7 is a potential tumor biomarker for A549 cells.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The gene for proteasome subunit alpha type-7 (PSMA7) is located in chromosomal region 20q13.33.
- This chromosomal region is frequently amplified in various tumors.
Purpose of the Study:
- To investigate the role of PSMA7 in the proliferation, tumorigenicity, and invasion of A549 human lung adenocarcinoma cells.
- To determine if PSMA7 can serve as a potential tumor biomarker.
Main Methods:
- Utilized A549 human lung adenocarcinoma cells for in vitro experiments.
- Conducted gain and loss of function studies.
- Employed a xenograft nude mice model to assess tumorigenicity in vivo.
Main Results:
- PSMA7 was found to inhibit the proliferation, tumorigenicity, and invasion of A549 cells in vitro.
- Gain and loss of function studies confirmed that PSMA7 modulates the tumorigenicity of A549 cells in a xenograft nude mice model.
Conclusions:
- PSMA7 exhibits inhibitory effects on the tumorigenicity of A549 lung adenocarcinoma cells.
- PSMA7 is identified as a potential tumor biomarker for lung adenocarcinoma.
